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Objectives. The purpose of this study was to determine the
impact of changes in flow on aortic valve area (AVA) as measured
by the Gorlin formula and transesophageal echocardiographic
(TEE) planimetry.
Background. The meaning of flow-related changes in AVA
calculations using the Gorlin formula in patients with aortic
stenosis remains controversial. It has been suggested that flow
dependence of the calculated area could be due to a true widening
of the orifice as flow increases or to a disproportionate flow
dependence of the formula itself. Alternatively, anatomic AVA can
be measured by direct planimetry of the valve orifice with TEE.
Methods. Simultaneous measurement of the planimetered and
Gorlin valve area was performed intraoperatively under different
hemodynamic conditions in 11 patients. Left ventricular and
ascending aortic pressures were measured simultaneously after
transventricular and aortic punctures. Changes in flow were
induced by dobutamine infusion. Using multiplane TEE, AVA was
planimetered at the level of the leaflet tips in the short-axis view.
Results. Overall, cardiac output, stroke volume and transval-
vular volume flow rate ranged from 2.5 to 7.3 liters/min, from 43
to 86 ml and from 102 to 306 ml/min, respectively. During
dobutamine infusion, cardiac output increased by 42% and mean
aortic valve gradient by 54%. When minimal flow was compared
with maximal flow, the Gorlin area varied from (mean 6 SD)
0.44 6 0.12 to 0.60 6 0.14 cm2 (p < 0.005). The mean change in
Gorlin area under different flow rates was 36 6 32%. Despite these
changes, there was no significant change in the planimetered area
when minimal flow was compared with maximal flow. The mean
difference in planimetered area under different flow rates was
0.002 6 0.01 cm2 (p 5 0.86).
Conclusions. By simultaneous determination of Gorlin formula
and TEE planimetry valve areas, we showed that acute changes in
transvalvular volume flow substantially altered valve area calcu-
lated by the Gorlin formula but did not result in significant
alterations of the anatomic valve area in aortic stenosis. These
results suggest that the flow-related variation in the Gorlin AVA is
due to a disproportionate flow dependence of the formula itself
and not a true change in valve area.
(J Am Coll Cardiol 1997;29:1296–302)
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Aortic valve area (AVA) has proved to be a valuable index for
the clinical management of patients with valvular aortic steno-
sis. Historically, this value has been derived from the Gorlin
formula utilizing catheterization data and, more recently, from
the continuity equation using both two-dimensional and Dopp-
ler data. Hemodynamic studies have revealed that the AVA
calculated from the Gorlin equation is not constant but varies
with flow (1–7). The meaning of these flow-related changes in
AVA remains controversial. Flow dependence could be due to
a true widening of the orifice as flow increases or to a
disproportionate flow dependence of the formula. Thus, the
data presently available do not delineate clearly whether the
degree of stenosis really does vary with changes in the valve-
opening force. The determinants of this force are the transval-
vular flow and velocity and systolic left ventricular pressure.
Therefore, hemodynamic and Doppler assessment of the se-
verity of aortic stenosis can present problems in low output
states (7).
Alternatively, the anatomic AVA can be measured reliably
by planimetry from short-axis images obtained with transesoph-
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ageal echocardiography (TEE) (8–13). The planimetered
AVA correlated well with both the Gorlin and continuity
equations in three studies (8,10,13). Good correlation was also
obtained when the planimetered valve area was compared with
direct intraoperative measurement of the anatomic area by the
surgeon in another study (9). Recently, it was demonstrated
(13) that acute changes in stroke volume do not result in
significant alterations in the AVA measured with multiplane
TEE. However, no study exists in which simultaneous cathe-
terization and TEE were performed to evaluate fluctuations in
the Gorlin valve area and to compare them with anatomic
planimetered AVA. Such data are essential to understand the
significance of flow-related changes in Gorlin valve area and, in
particular, to test the concept of overdependence of flow of
this calculated area. The purpose of the present study was to
determine the impact of changes in flow on the AVA by
simultaneous determination of Gorlin formula and TEE
planimetry valve areas in patients with aortic stenosis.
Methods
Study patients. The study protocol was approved by the
institutional research and ethics committees of the Montreal
Heart Institute. Written informed consent was obtained from
each patient. The study included 11 patients (3 men, 8 women;
38 to 82 years old, mean age 63) who were undergoing aortic
valve replacement. AVA measured with transthoracic echocar-
diography using the continuity equation ranged from 0.24 to
0.70 cm2 (mean [6SD] 0.58 6 0.15). Mean pressure gradient
measured with transthoracic echocardiography ranged from 38
to 95 mm Hg (mean 61 6 15). Aortic regurgitation was mild or
absent in all patients, according to standard angiographic and
transthoracic echocardiographic criteria. Because of the need
for dobutamine infusion during the study, patients with a
coronary artery narrowing .50% in diameter at angiography
were excluded. Simultaneous determination of Gorlin formula
and TEE planimetry AVAs were performed in the operating
room under different transvalvular flow conditions.
Hemodynamic monitoring. A pulmonary artery catheter
was inserted before intubation of the patient. After sternotomy
and before going on cardiopulmonary bypass, left ventricular
and ascending aortic punctures were performed using fine
needles (21 gauge). The fluid-filled catheters were manipu-
lated to avoid left ventricular entrapment and to obtain
artifact-free ascending aortic pressure tracings. Left ventricu-
lar and ascending aortic pressures were measured simulta-
neously. Monitoring of heart rate and left ventricular, ascend-
ing aortic, right atrial and pulmonary artery pressures was
continuously done throughout the protocol. Cardiac output
was determined by thermodilution with averaging of three
measurements.
Multiplane TEE. We used a multiplane TEE instrument
(Omniplane, Hewlett-Packard) composed of a 64-element
phased-array transducer that has a dual-frequency feature
allowing two-dimensional imaging at 5 and 3.7 MHz (14). The
transducer array can be rotated through a 180° arc. The
multiplane probe is interfaced to the ultrasound imaging
console (HP Sonos 1500, Hewlett-Packard) and the operation
of the console is similar to that of conventional echocardiog-
raphy. The entire examination was recorded on 0.5-in.
(1.27 cm) VHS videotape. The procedure was performed as
previously described (14). The probe was introduced after the
induction of general anesthesia and tracheal intubation. The
first part of the examination consisted of image acquisition at
different levels and in various planes to perform a systematic
evaluation of cardiovascular structures. Examination of the
aortic valve was then performed. To define the optimal level of
the transducer location for subsequent planimetry of the aortic
valve in the short-axis view, the leaflets tips were initially
positioned in the center of the two-dimensional sector in the
long-axis view of the aortic valve and ascending aorta (110° to
160°). With the transducer position held stable, the ultrasound
array was steered to obtain a short-axis view of the aortic valve.
This was usually possible between 30° and 70°. Minimal probe
manipulation was performed to ensure that the smallest orifice
of the aortic valve (at its tips) was identified. The view was
considered adequate for planimetry if the aorta had a circular
shape and all aortic cusps were visualized simultaneously.
Special care was taken to optimize gain settings and gray scale.
The short-axis view of the aortic valve was then held stable
before and during changes in cardiac output.
Hemodynamic manipulation. Changes in cardiac output
were induced by an infusion of dobutamine. After obtaining
baseline hemodynamic and transesophageal data, a graded
infusion of dobutamine was begun at 5 mg/kg body weight per
min and doubled until cardiac output increased significantly or
up to 20 mg/kg per min. Changes .15% between three
averaged cardiac output measurements were considered sig-
nificant (15,16). Repeat hemodynamic measurements and
TEE studies were recorded during steady state dobutamine
infusion.
Analysis of hemodynamic data. Mean transvalvular aortic
pressure gradient was derived from planimetry of simultaneous
high speed left ventricular and ascending aortic pressure
recordings. AVA was calculated using the Gorlin formula:
Cardiac output/(Heart rate 3 Systolic ejection period 3
44.3 3 =DP). Mean aortic pressure gradient and Gorlin valve
area were calculated off-line separately at baseline and at
steady state dobutamine infusion, with the observer blinded to
results of transthoracic and TEEs, and to results obtained with
different hemodynamic conditions. Transvalvular flow rate was
obtained by dividing stroke volume (Cardiac output/Heart
rate) by the systolic ejection period.
Planimetry of aortic valve by multiplane TEE. AVA was
determined off-line at baseline and at steady state dobutamine
Abbreviations and Acronyms
AVA 5 aortic valve area
TEE 5 transesophageal echocardiography (echocardiographic)
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infusion. All measurements were done by planimetry of the
aortic valve in the short-axis view on the same imaging console
using the multiplane images considered most appropriate by
an experienced observer. The observer had no knowledge of
the results of cardiac catheterization and TEE, the changes in
intraoperative hemodynamic findings and the results of
planimetry obtained with different hemodynamic profiles. At
least three consecutive measurements of AVA were averaged
for a given hemodynamic profile in patients in sinus rhythm; no
patient had atrial fibrillation in this study. Intraobserver vari-
ability was determined by reanalysis of all the measurements by
a single observer at an interval of at least 2 weeks. Interob-
server variability was determined by independent analysis by
two blinded experienced observers. Intraobserver and interob-
server variability for TEE measurements of aortic valve area is
7.9 6 6.2% and 11.6 6 8.8%, respectively.
Ability of multiplane TEE to detect changes in AVA. The
true orifice area of aortic bioprostheses is known to decrease at
very low flow (1). To demonstrate the ability of multiplane
transesophageal imaging to detect actual changes in valve area,
we studied four other patients with aortic bioprostheses under
different flow conditions. After aortic valve replacement, mul-
tiplane TEE was performed as patients were very slowly
weaned from cardiopulmonary bypass (from total extracorpo-
real circulation), in 0.25-liter/min increments for 1 liter and in
0.5-liter/min increments thereafter.
Statistical analysis. Results are presented as mean value 6
SD. Because we were studying the effect of flow on valve area,
and not the effect of dobutamine itself, data were compared at
minimal (lower flow rate) and maximal (higher flow rate) flow
conditions for each patient. For patients in whom there was a
decrease in flow rate despite an increase in cardiac output
during dobutamine infusion, results obtained during dobut-
amine infusion represented minimal flow rate, and baseline
values had to be taken as maximal flow rate data. A similar
analysis was performed comparing minimal with maximal
stroke volume. Measurements of Gorlin formula or TEE
planimetry AVAs were compared at minimal and maximal
transvalvular flow conditions (both flow rate and stroke vol-
ume) by using a paired t test. Differences were considered
significant at p , 0.05.
Results
Description of valve morphology and mobility. In all pa-
tients, we were able to obtain short-axis images of the aortic
valve adequate for measurement (Fig. 1 and 2). The valve
orifice at its tips, and its shape, were well displayed in the
images at all hemodynamic settings. The leaflets were thick-
ened in all patients and mildly or moderately calcified in seven
patients; four aortic valves were severely calcified. Differenti-
ation of bicuspid from tricuspid valve morphology was occa-
sionally difficult in these patients with aortic valve calcification.
However, five patients appeared to have a bicuspid aortic
valve. After quantitative measurements were done in blinded
and random manner, the recordings of each patient at baseline
and during infusion of dobutamine were reviewed together.
There was no significant difference in the systolic mobility of
the aortic valve leaflets from minimal to maximal transvalvular
flow rate, in the long-axis view.
Effects of changes of transvalvular flow on Gorlin formula
AVA. Overall, cardiac output and mean transvalvular aortic
pressure gradient ranged from 2.5 to 7.3 liter/min and from 34
to 111 mm Hg, whereas stroke volume and transvalvular
volume flow rate ranged from 43 to 86 ml and from 102 to
306 ml/s, respectively (Table 1). Cardiac output increased from
3.9 6 1.1 liters/min at baseline to 5.6 6 1.1 liters/min during
dobutamine infusion, representing a 42 6 27% increase from
baseline (p , 0.0001). Mean aortic pressure gradient varied
from 51 6 12 mm Hg at baseline to 78 6 19 mm Hg during
dobutamine infusion, a 54 6 24% increase (p , 0.0001) (Fig.
1 and 2). Transvalvular volume flow rate increased from 145 6
33 to 217 6 41 ml/s and stroke volume varied from 50 6 12 to
66 6 10 ml from minimal to maximal flow conditions (p #
Figure 1. Simultaneous multiplane TEE image of aortic
valve and left ventricular and ascending aortic pressure
tracings at baseline in a patient with severe aortic stenosis.
Planimetry of the aortic valve at baseline (lower left) and
after increase in transvalvular flow with an infusion of
dobutamine (Fig. 2) did not demonstrate significant changes
in the anatomic orifice area (0.54 cm2). The electrocardio-
graphic tracing (lower left) to the right of the gray bar
represents previous cycles. CIRC 5 circumference; CO 5
cardiac output; HR 5 heart rate; SEP 5 systolic ejection
period; DP 5 pressure gradient.
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0.001). The percent increases in transvalvular flow rate and
stroke volume were 53% and 38%, respectively.
When minimal and maximal transvalvular volume flow rates
were compared, the Gorlin formula AVA varied from 0.45 6
0.12 cm2 to 0.60 6 0.14 cm2 (p , 0.01). Because there was a
minor divergent response of flow rate and stroke volume
during dobutamine infusion in one patient, we also compared
valve area from minimal to maximal stroke volume. In this
analysis, the Gorlin valve area increased from 0.44 6 0.12 cm2
to 0.60 6 0.14 cm2 (p , 0.005). The mean difference in
Gorlin valve area under different stroke volumes was 0.16 6
0.14 cm2. The absolute change in valve area from minimal
to maximal stroke volume ranged from 0.02 to 0.48 cm2
(Fig. 3).
Effects of changes of transvalvular flow on TEE planimetry
AVA. Despite these changes in transvalvular flow and Gorlin
valve area, there was no significant change in AVA measured
with TEE planimetry when minimal and maximal transvalvular
volume flow rates were compared (from 0.51 6 0.15 cm2 to
0.51 6 0.15 cm2). The mean difference in planimetered aortic
valve area under different flow rates was 0.002 6 0.01 cm2 (p 5
0.86). The absolute change ranged from 20.02 to 0.02 cm2; the
largest increase in planimetered valve area from minimal to
maximal transvalvular flow rate was 0.02 cm2 in one patient
(Fig. 3).
Ability of multiplane TEE to detect changes in AVA. The
bioprosthetic orifice area (measured with multiplane TEE)
gradually increased from 0.87 to 1.30 cm2 for 21-mm valves and
from 1.46 to 1.75 cm2 for 23-mm valves when normal antero-
grade flow was increased from 0.25 to 2.0 liters/min (Fig. 4) as
patients were weaned from cardiopulmonary bypass after
aortic valve replacement. The orifice area remained stable
thereafter. The smallest change in valve area detected in these
patients was 0.05 cm2.
Figure 2. Simultaneous multiplane TEE image of aortic
valve and left ventricular and ascending aortic pressure
tracings during steady state dobutamine infusion in the
same patient as in Figure 1. AVA calculated with the Gorlin
formula increased from 0.51 cm2 at baseline (Fig. 1) to
0.99 cm2 during dobutamine infusion (right). Abbreviations
as in Figure 1.
Table 1. Intraoperative Hemodynamic and Transesophageal Echocardiographic Data
Pt
No.
Baseline Dobutamine
CO HR SV SEP FR DP AVR AVA TEE CO HR SV SEP FR DP AVR AVA TEE
1* 4.8 75 64 0.40 160 54.8 456 0.48 0.67 6.4 115 56 0.48 116 110.5 1268 0.25 0.66
2 3.0 69 43 0.36 121 34.1 376 0.46 0.64 4.7 69 68 0.36 189 57.3 403 0.56 0.65
3 5.6 89 63 0.32 197 59.6 403 0.57 0.46 6.2 103 60 0.26 232 99.2 570 0.52 0.46
4 2.7 37 73 0.40 182 48.7 355 0.59 0.45 5.4 67 81 0.36 224 67.6 402 0.61 0.45
5 4.8 110 44 0.28 156 42.4 362 0.54 0.52 7.3 115 63 0.28 227 74.0 434 0.59 0.51
6 3.8 86 44 0.32 138 36.3 350 0.51 0.54 6.7 78 86 0.28 307 48.9 212 0.99 0.54
7 3.3 65 51 0.40 127 66.5 697 0.35 0.29 5.3 79 67 0.32 210 99.8 633 0.47 0.29
8 5.2 88 56 0.36 166 64.9 526 0.46 0.28 5.8 88 66 0.32 206 86.3 557 0.50 0.27
9 3.3 72 46 0.40 115 61.9 718 0.33 0.39 4.9 91 54 0.24 224 74.3 440 0.59 0.41
10 4.3 84 51 0.28 183 49.9 363 0.58 0.66 5.3 88 60 0.24 251 70.7 375 0.67 0.64
11* 2.5 48 52 0.32 163 40.3 330 0.58 0.72 3.3 129 26 0.25 102 67.3 875 0.28 0.71
*Data are presented in the text at minimal and maximal flow rates for each patient. For patients in whom there was a decrease in flow rate (despite an increase
in cardiac output) during dobutamine infusion (Patients 1 and 11), results obtained during dobutamine infusion represent minimal flow rate data. AVA 5 Gorlin aortic
valve area (cm2); AVR 5 aortic valve resistance (dynes 3 s 3 cm25); CO 5 cardiac output (liters/min); FR 5 flow rate (ml/s); HR 5 heart rate (beats/min); DP 5
mean pressure gradient using catheterization data (mm Hg); SEP 5 systolic ejection period (s); SV 5 stroke volume (ml); TEE 5 transesophageal echocardiographic
planimetry of aortic valve area (cm2).
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Discussion
In our study, simultaneous determination of Gorlin formula
and TEE planimetry AVAs shows that changes in transvalvular
flow and in the Gorlin valve area were not associated with
alterations of the directly planimetered valve area.
Development of Gorlin formula. Peak to peak and mean
pressure gradients measured invasively are useful indexes of
the severity of aortic stenosis. However, these values are
known to vary with flow, which can lead to underestimation of
the severity of the lesion in patients with low cardiac output
and low pressure gradient. By taking into account both cardiac
output and pressure gradient, Gorlin and Gorlin (17) in their
pioneer work of 1951 expected to eliminate dependence on
flow. They developed their formula based on the Torricelli
model of nonturbulent flow through an orifice where flow was
proportional to the square root of the pressure gradient. A
constant, accounting for orifice contraction and energy loss as
pressure energy is converted into kinetic energy, had to be
introduced. For calculation of mitral valve area, a constant
(0.83) was determined by correlating the calculated mitral
valve areas of 11 patients with measurements obtained at
autopsy or by intraoperative digital palpation (17). When
calculating the AVA, Gorlin and Gorlin empirically decided to
use a constant of 1.
Limitations of Gorlin formula in aortic stenosis. Although
the formula has been used clinically for many years, confirma-
tion of its accuracy as applied to AVA is still uncertain (18).
Indeed changes have frequently been observed in the calcu-
lated AVA with modifications in cardiac output (1–7). This
may be explained by two factors. A true widening of the orifice
area could occur with an increase in the valve-opening force
(19), which is related to left ventricular pressure, stroke
volume and transvalvular flow rate. Alternatively, the in-
creased area with increased flow could be due to a dispropor-
tionate flow dependence of the formula itself. Efforts have
been made to try to solve the controversy. In one study (2), the
AVA calculated with the Gorlin formula increased in all the
patients who received dobutamine, whereas the AVA mea-
sured with the continuity equation did not change. This finding
suggested that changes in the calculated valve area reflected
flow dependence of the Gorlin formula. Additionally, it has
been demonstrated (1) that the constant in the Gorlin formula
is not constant but varies directly with the square root of the
pressure gradient. A new equation was therefore proposed by
Cannon et al. (1) who used the first power, rather than the
square root of the gradient, to increase the importance of the
gradient and make the formula less flow dependent. However,
this equation has not yet been validated with native valvular
Figure 3. Diagram showing the flow-related change in AVA calculated
with the Gorlin formula for each patient and the lack of significant
variation in planimetered valve area using multiplane TEE (Echo).
Figure 4. Multiplane TEE images of an aortic bioprosthesis in a
patient being weaned from cardiopulmonary bypass. There was an
obvious modification in orifice area as normal anterograde flow
increased. The bioprosthetic orifice area gradually increased from
0.85 cm2 (A) to 1.28 cm2 (B) when normal anterograde flow was
increased from 0.25 to 2.0 liters/min. The orifice area remained stable
thereafter. The smallest change in valve area detected in this patient
was 0.06 cm2.
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aortic stenosis and is not in routine clinical use. Using the first
power of the pressure gradient, aortic valve resistance has also
been shown (20) to be less dependent on flow than the area
calculated with the Gorlin equation. Importantly, resistance
has also been shown (21) to help distinguish truly severe from
milder aortic obstruction with similar calculated valve areas.
Our data also point to another potential limitation of area
calculation with the Gorlin formula. Although the formula is
based on measurements of mean flow and mean pressure
gradient, Gorlin and Gorlin (17) added correction factors to
allow for correlation with the area of maximally opened valves
measured at autopsy or by intraoperative digital palpation.
Thus, the Gorlin valve area was corrected to correlate with the
instantaneous maximal anatomic area, similar to that obtained
with direct echocardiographic planimetry. In our two patients
(Patients 1 and 11) who had a decrease in transvalvular flow
rate and stroke volume and a higher pressure gradient during
dobutamine infusion, there was a resultant decrease in the
valve area calculated with the Gorlin formula. However, the
planimetered valve area remained stable in these two patients.
Because of the predetermined relation between flow rate,
stroke volume and pressure gradient in the Gorlin equation, it
is impossible to have a higher pressure gradient with a smaller
stroke volume and flow rate without a simultaneous decrease
in the calculated valve area. However, determinants of fluid
dynamics other than changes in kinetic effects are not taken
into consideration in the Gorlin formula. It is possible to
explain why the anatomic (planimetered) orifice area did not
change in Patients 1 and 11 by considering the complexities of
pulsatile flow across a stenotic aortic valve and, in particular,
the effects of viscous forces and local acceleration on instan-
taneous pressure drop. An increase in pressure drop due to
viscous forces may have occurred during dobutamine infusion
in these patients because of the significant decrease in flow
rate. Indeed it has been demonstrated (22) that the hydraulic
discharge coefficient (Cd) in the Gorlin formula is not constant
but can decrease under low flow conditions, causing an under-
estimation of valve area. The pressure drop caused by flow
acceleration, or the force necessary to overcome inertia, may
also have increased significantly in Patients 1 and 11, partly due
to the large increases in heart rate (from 75 to 115 beats/min
and from 48 to 129 beats/min) during dobutamine infusion
(23). Indeed these two patients were the only ones in our study
with heart rates .100 beats/min and an increase in heart rate
.50% with dobutamine infusion. The mean change in heart
rate was 111% in these patients but only 16% in the other
patients. Thus, although the Gorlin formula was originally
intended to correlate with the maximal anatomic valve area, it
is occasionally impossible to predict changes in this instanta-
neous maximal value from the relatively simple Gorlin rela-
tion, which uses mean data and only assesses changes in kinetic
effects.
Use of continuity equation for calculation of AVA. A
noninvasive alternative for the evaluation of aortic stenosis has
been made available with the advent of Doppler echocardiog-
raphy. Using experimental models, Segal et al. (22) have
suggested that the continuity equation may be more accurate
than the Gorlin formula because a constant does not need to
be assumed for energy loss (discharge coefficient) in the
former. In a clinical study (2), AVA measured with the
continuity equation and valve resistance did not change with
increases in cardiac output, despite fluctuations in the values
derived with the Gorlin equation. In a more recent animal
study with experimentally created aortic stenosis (7), valve area
measured with the continuity equation also varied with
changes in flow, leading to the hypothesis that the anatomic
valve area may change with flow. However, no significant
change in the planimetered area of a stenotic valve was
observed in vitro over a 250% change in flow rate in another
study (1). Potential pitfalls associated with use of the continuity
equation include the difficulty of accurately measuring the left
ventricular outflow tract diameter and carefully defining the
maximal aortic flow velocity and left ventricular outflow tract
velocity before flow acceleration. All these observations sug-
gested the absence of an ideal reference standard for assess-
ment of AVA.
TEE planimetry in aortic stenosis. The value of TEE in the
assessment of the severity of aortic stenosis has previously been
demonstrated (8–13). The anatomic valve area measured with
biplane and multiplane TEE has been shown to correlate well
with calculation of AVA utilizing the Gorlin formula at
catheterization, with the continuity equation during trans-
thoracic echocardiography and with direct intraoperative mea-
surement (8–10,13). Nevertheless, potential problems exist for
planimetry of the aortic valve with TEE. To measure the AVA
accurately, the transducer must be located at the tips of the
valve leaflets. The longitudinal motion of the aortic root during
the cardiac cycle needs to be taken into account. Confirmation
of the appropriate imaging level can be obtained by carefully
positioning the valve tips in the center of the sector in the
long-axis orientation, and subsequently rotating the ultrasound
array from that location to a short-axis view. Furthermore,
simultaneous visualization of all the cusps in an adequate
short-axis orientation is important before considering an image
plane adequate for assessment. In our study, planimetry was
possible in all patients, even those with severe calcification or
very small valve areas. However, planimetry may occasionally
be more difficult to perform in the presence of heavy calcifi-
cations. Intraobserver and interobserver variability was low
and similar to that reported in previous studies. Importantly,
we demonstrated the ability of multiplane TEE to detect
changes in valve area by studying aortic bioprostheses under
different flow conditions. Changes in orifice area had previ-
ously been demonstrated (1) in aortic bioprostheses at very low
flow, with direct videotape of valve operation in vitro. The
smallest change in planimetered area that we detected in our
study in aortic bioprostheses was smaller than the flow-related
variations in native AVA calculated with the Gorlin formula.
Thus, the possibility that multiplane TEE was insensitive to
true flow-related changes in Gorlin valve area was excluded.
Sprigings et al. (24) observed in three excised stenotic aortic
valves that the anatomic valve area (measured from direct
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videotaping) increased by an average of 38% when stroke
volume was augmented in vitro from 40 to 100 ml. Although
their results vary from ours, several aspects of this in vitro
model may differ from the clinical scenario (25). In particular,
expansion of the aortic root may be an important mechanism
contributing to valve opening in vivo, whereas the expansibility
of the in vitro model was limited.
Limitations of the study. The changes in flow obtained in
our patients with aortic stenosis were significant but limited.
Previous studies (2–6) that have demonstrated variation in the
Gorlin formula valve area had changes in flow that were
similar to those obtained in our study. The relative change in
Gorlin AVA that we observed with alterations in flow was also
similar to the variations reported in those studies (2–7). The
data presented here were acquired in patients with severe
aortic stenosis. However, similar results were recently obtained
with moderate aortic stenosis (13). Although similar data are
not available for milder obstruction, possible flow-related
variations in patients with greater native valve areas would
nevertheless be less significant clinically. Because the 32 pa-
tients studied in the present and previous studies (13) were
.35 years old, our results may not apply to younger patients
with congenital, noncalcific aortic stenosis. Finally, the rela-
tively small size of our patient cohort was another study
limitation.
Clinical implications. Simultaneous catheterization and
multiplane TEE data demonstrating flow-related variation in
the Gorlin valve area with a stable anatomic planimetered
valve area provides strong evidence for an overdependence of
flow in the Gorlin formula in the evaluation of AVA. We also
demonstrated in this study the ability of multiplane TEE to
detect changes in valve area in other circumstances (aortic
bioprostheses). In view of these considerations, planimetry of
the AVA with multiplane TEE could offer a more accurate
evaluation of aortic stenosis than that obtained with the use of
the Gorlin formula in patients with a moderate to severe
reduction of AVA. In particular, our findings should raise
questions as to the reliability of the Gorlin formula in patients
with low cardiac output and small AVAs and should lead to
increased use of multiplane TEE in the clinical assessment of
aortic stenosis.
We thank Stanley Nattel, MD for careful review of the manuscript.
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